SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+19.42%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$1.87B
AUM Growth
+$1.87B
(-9.8%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-21.13%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
114
New
19
Increased
26
Reduced
20
Closed
11
Top Buys
| 1 |
Las Vegas Sands
LVS
|
$39.7M |
| 2 |
NVIDIA
NVDA
|
$32.8M |
| 3 |
Global Payments
GPN
|
$27.7M |
| 4 |
RH
RH
|
$27.4M |
| 5 |
TSMC
TSM
|
$23.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$73.2M |
| 2 |
Elevance Health
ELV
|
$67.7M |
| 3 |
Constellation Energy
CEG
|
$56.8M |
| 4 |
Estee Lauder
EL
|
$56.4M |
| 5 |
Colgate-Palmolive
CL
|
$54.4M |
Sector Composition
| 1 | Healthcare | 61.36% |
| 2 | Technology | 11.67% |
| 3 | Consumer Discretionary | 8.46% |
| 4 | Communication Services | 5.69% |
| 5 | Financials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Royalty Pharma
RPRX
$15.6B
| $93.7M | 5.01% | 3,047,049 | – | – |
|
2
Biohaven
BHVN
$1.63B
| $92.5M | 4.95% | 3,867,558 +18,620 | +0.5% | +$445K |
|
3
Arcellx
ACLX
$3.85B
| $90.1M | 4.82% | 2,848,167 +449,846 | +19% | +$14.2M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $81.6M | 4.36% | 793,355 -180,400 | -19% | -$18.6M |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $75.9M | 4.06% | 1,198,971 | – | – |
|
6
Kura Oncology
KURA
$686M
| $74.4M | 3.98% | 7,028,442 +455,107 | +7% | +$4.82M |
|
7
Meta Platforms (Facebook)
META
$1.86T
| $72.1M | 3.85% | 251,230 -102,968 | -29% | -$29.5M |
|
|
KDNY
8
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $67.2M | 3.59% | 1,748,141 +179,344 | +11% | +$6.89M |
|
9
Insmed
INSM
$28.8B
| $65.6M | 3.51% | 3,109,334 +177,196 | +6% | +$3.74M |
|
10
Terns Pharmaceuticals
TERN
$609M
| $48.7M | 2.6% | 5,561,835 +2,113,560 | +61% | +$18.5M |
|
11
89bio
ETNB
$1.34B
| $45.4M | 2.42% | 2,393,236 +182,700 | +8% | +$3.46M |
|
|
MRNS
12
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $44.1M | 2.36% | 4,057,611 -773,650 | -16% | -$8.4M |
|
13
Amazon
AMZN
$2.44T
| $42.7M | 2.29% | 327,913 -231,577 | -41% | -$30.2M |
|
14
Advanced Micro Devices
AMD
$264B
| $42.2M | 2.26% | 370,607 -252,309 | -41% | -$28.7M |
|
|
15
Las Vegas Sands
LVS
$39.6B
| $39.7M | 2.13% | +685,233 | New | +$39.7M |
|
16
Oracle
ORCL
$635B
| $37.9M | 2.03% | 318,425 -48,088 | -13% | -$5.73M |
|
17
ProKidney
PROK
$319M
| $35.7M | 1.91% | 3,193,175 | – | – |
|
|
18
NVIDIA
NVDA
$4.24T
| $32.8M | 1.75% | +77,492 | New | +$32.8M |
|
19
Wynn Resorts
WYNN
$13.2B
| $31.5M | 1.69% | 298,658 -351,103 | -54% | -$37.1M |
|
20
EyePoint Pharmaceuticals
EYPT
$797M
| $29.8M | 1.59% | 3,423,897 +29,000 | +0.9% | +$252K |
|
|
XYZ
21
Block, Inc.
XYZ
$48.5B
| $28.8M | 1.54% | 432,296 +64,856 | +18% | +$4.32M |
|
|
22
Global Payments
GPN
$21.5B
| $27.7M | 1.48% | +281,188 | New | +$27.7M |
|
|
23
RH
RH
$4.23B
| $27.4M | 1.47% | +83,189 | New | +$27.4M |
|
24
Sutro Biopharma
STRO
$72.7M
| $27.4M | 1.46% | 5,883,693 +194,607 | +3% | +$905K |
|
25
Cogent Biosciences
COGT
$1.69B
| $26.3M | 1.41% | 2,219,693 +400,000 | +22% | +$4.74M |
|